Please Wait
Applying Filters...
menu
    • menu
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Nadifloxacin

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,303Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Opocrin SpA
    Italy
    		 Bukwang Pharmaceutical Co., Ltd. 2662-1-ND(1) Nadifloxacin 2011-08-19 Otsuka Pharmaceutical Co., Ltd. Japan Second Tokushima Factory 224-18, Hiraishi Ebisuno, Kawauchi-cho, Tokushima-shi, Tokushima, Japan
    28/09/2024 Opocrin SpA
    Italy
    		 Korea Otsuka Pharmaceutical Co., Ltd. 2662-1-ND Nadifloxacin 2007-05-04 Otsuka Pharmaceutical Co., Ltd. Second Tokushima Factory Japan 224-18, Hiraishi Ebosuno, Kawauchi-cho, Tokushima-shi, Tokushima, Japan